Abstract

Background To determine temporal changes in the prevalence and associates of lower extremity amputation (LEA) complicating type 2 diabetes.Methods Baseline data from the longitudinal observational Fremantle Diabetes Study (FDS) relating to LEA and its risk factors collected from 1296 patients recruited to FDS Phase 1 (FDS1) from 1993 to 1996 and from 1509 patients recruited to FDS Phase 2 (FDS2) from 2008 to 2011 were analysed. Multiple logistic regression was used to determine associates of prevalent LEA in individual and pooled phases. Generalised linear modelling was used to examine whether diabetes related LEA prevalence and its associates had changed between Phases.ResultsThere were 15 diabetes-related LEAs at baseline in FDS1 (1.2 %) and 15 in FDS2 (1.0 %; P = 0.22 after age, sex and race/ethnicity adjustment). In multivariable analysis, independent associates of a baseline LEA in FDS1 were a history of vascular bypass surgery or revascularisation, urinary albumin:creatinine ratio, peripheral sensory neuropathy and cerebrovascular disease (P ≤ 0.035). In FDS2, prevalent LEA was independently associated with a history of vascular bypass surgery or revascularisation, past hospitalisation for/current foot ulcer and fasting serum glucose (P ≤ 0.001). In pooled analyses, a history of vascular bypass or revascularisation, past hospitalisation for/current foot ulcer at baseline, urinary albumin:creatinine ratio (P < 0.001), as well as FDS Phase as a binary variable [odds ratio (95 % confidence interval): 0.28 (0.09–0.84) for FDS2 vs FDS1, P = 0.023] were associated with a lower risk of LEA at study entry.ConclusionsThe risk of prevalent LEA in two cohorts of patients with type 2 diabetes from the same Australian community fell by 72 % over a 15-year period after adjustment for important between-group differences in diabetes-related and other variables. This improvement reflects primary care foot health-related initiatives introduced between Phases, and should have important individual and societal benefits against a background of a progressively increasing diabetes burden.

Highlights

  • To determine temporal changes in the prevalence and associates of lower extremity amputation (LEA) complicating type 2 diabetes

  • In FDS Phase 2 (FDS2) vs Fremantle Diabetes Study Phase 1 (FDS1) there was a greater proportion of Aborigines, diabetes diagnosis was at a younger age, diabetes duration was longer, more were overweight/obese, and alcohol consumption was higher but more were current smokers

  • In multiple logistic regression analysis, independent associates of a baseline LEA in FDS1 were a history of vascular bypass surgery or revascularisation, urinary albumin:creatinine ratio, peripheral sensory neuropathy (PSN) and cerebrovascular disease

Read more

Summary

Introduction

To determine temporal changes in the prevalence and associates of lower extremity amputation (LEA) complicating type 2 diabetes. Baba et al Cardiovasc Diabetol (2015) 14:152 reduction in the rates of this complication [3, 10,11,12,13], but some have shown no change [14,15,16] or an increase [17]. Interpretation of the results of clinic- and populationbased studies is, complicated by limitations such as use of selected patient samples, a restricted range of explanatory and confounding variables, and lack of interpretation of the findings in the light of changes in management that could have an impact on foot health. There is, the need for an assessment of temporal changes in LEA rates in community-based patient groups and in health care systems, both of which are well-characterised. The aims of the present study were, (1) to determine whether the prevalence of LEA has changed in comprehensively assessed patients with type 2 diabetes resident in a large urban Australian population in the 15 years between 1993–1996 and 2008–2011, and (2) to assess the relationship between any changes in established risk factors for LEA and its prevalence over the same period

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.